EXAS

Exact Sciences Corporation

Price

return (12m)

p/e

-95.86

p/bv

8.30

DIVIDEND YIELD

0.00%

EXAS price

Exact Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EXAS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals EXAS

Valuation

P/E

-95.86

Sector -3.50

Industry -3.50

P/BV

8.30

Sector 2.02

Industry 2.02

P/Revenue (PSR)

6.14

Sector 2.01

Industry 2.01

EV/EBITDA

-903.11

Sector -214.99

Industry -214.99

EV/EBIT

-266.43

Sector -47.59

Industry -47.59

P/EBITDA

-1,251.28

Sector -21.41

Industry -21.41

P/EBIT

-109.39

Sector -28.65

Industry -28.65

P/Total Assets

3.40

Sector 1.19

Industry 1.19

P/Net Current Assets

-10.47

Sector -11.97

Industry -11.97

P/Working Capital

21.79

Sector -167.95

Industry -167.95

EPS

-1.09

Sector -1.81

Industry -1.81

BVPS

12.64

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

69.69%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-2.68%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-9.10%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-6.13%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-6.40%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.15

Sector 0.02

Industry 0.02

Profitability

ROE

-8.66%

Sector -56.04%

Industry -56.04%

ROA

-3.55%

Sector -60.31%

Industry -60.31%

ROIC

-7.31%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.43

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-57.78

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-17.05

Sector -8.06

Industry -8.06

Net Debt / Equity

0.57

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.97

Sector -0.85

Industry -0.85

Equity/Assets

0.41

Sector 0.46

Industry 0.46

Liabilities/Assets

0.59

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

12.94%

Sector -

Industry -

5Y Earnings CAGR

-18.98%

Sector -

Industry -

Fundamentals EXAS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EXAS Exact Sciences Corporation	$0.00	-100.00%	0.00%	-95.86	8.30	-8.66%	-6.40%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EXAS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Exact Sciences

Exact Sciences Corporation

Average Investor10 user rating

4.0 (2 people)

United States

31 years

Founded: 1995

2001

Time since IPO - 25 years

4.110

Employees

Exact Sciences Corporation (United States) is listed on the Nasdaq and has a market capitalization of $19.93 billion, with shareholders equity totaling $2.40 billion.

The company employs approximately 4.110 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Exact Sciences Corporation reported $3.25 billion in revenue, generating net income of $-207.94 million.

Key financial metrics include a P/E ratio of -95.86, a price-to-book (P/B) ratio of 8.30, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EXAS.

Market cap

$19.93 billion

Net worth

$2.40 billion

$2,401,050,000.00

Assets

$5.86 billion

$5,860,630,000.00

Total Shares Outstanding

190.00 million

190,000,000

Average Daily Trading Volume

$2.86 million

$2,857,152.96

Sector

Health Care

Industry

Biotechnology

EXAS

EXAS revenue and profits

Financial Results EXAS

DRAG THE FRAME TO SEE MORE DATA

EXAS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Exact Sciences (EXAS) today?

A cotação de Exact Sciences (EXAS) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Exact Sciences (EXAS) iniciou o ano negociando na casa dos US$ 101.56 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Exact Sciences (EXAS) e dados de ações do Ibovespa e mercados internacionais.

Quando Exact Sciences (EXAS) paga dividendos?

Exact Sciences (EXAS) não distribuiu dividendos no último ano.

Is Exact Sciences (EXAS) a good investment?

Atualmente, Exact Sciences (EXAS) está cotada a US$ 0.00, com um P/L de -95.86, representando um desvio de -4,644% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Exact Sciences (EXAS) stock?

Investir em ações de Exact Sciences (EXAS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Exact Sciences (EXAS) yield today?

A rentabilidade de Exact Sciences (EXAS) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Exact Sciences (EXAS) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

EXAS

Exact Sciences Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment EXAS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING EXAS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Exact Sciences

Exact Sciences Corporation

United States

31 years

2001

4.110

PROFIT X PRICE EXAS

Financial Results EXAS

EXAS cash flow

Asset, Revenue and Profit Growth - EXAS

EXAS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions